You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pancreatic ductal adenocarcinoma (PDA)Neoplasms

Showing 1 - 25 of 6,909
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Adenocarcinoma Trial in Suwon (Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts

Recruiting
  • Pancreas Adenocarcinoma
  • Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts establishment group
  • Suwon, Gyeong Gi Do, Korea, Republic of
    Ajou University Hospital
Oct 7, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)

Not yet recruiting
  • Pancreatic Cancer
  • +4 more
  • Screening Blood Tests
  • +3 more
  • Boston, Massachusetts
  • +1 more
Nov 3, 2023

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Bio-specimen Collection: Blood
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Oligometastatic Disease
  • FOLFIRINOX chemotherapy
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 2, 2023

Minimal Residual Disease Using Multi-omics Approach

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
  • Shanghai, China
    Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Nov 29, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +12 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 30, 2022

Predict Lymphovascular Invasion in Pancreatic Ductal

Recruiting
  • Predictive Cancer Model
  • Pancreas Cancer
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Aug 10, 2023

    Pancreatic Ductal Adenocarcinoma, Pain, Acute Trial in San Francisco (Ketamine, Meaning and Purpose therapy)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Pain, Acute
    • San Francisco, California
      University of California, San Francisco
    Oct 12, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

    Not yet recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Washington, District of Columbia
      Georgetown Lombardi Comprehensive Cancer Center
    Jan 23, 2023

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Indianapolis (Lonsurf, Gemcitabine, Nab-Paclitaxel)

    Active, not recruiting
    • Pancreatic Cancer
    • Pancreatic Ductal Adenocarcinoma
    • Indianapolis, Indiana
      Indiana University Melvin & Bren Simon Cancer Center
    Nov 29, 2022

    Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

    Recruiting
    • Adenocarcinoma, Pancreatic Ductal
    • Autogene cevumeran
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 21, 2023

    Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center, Georgetown University
    Apr 11, 2023

    Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Stereotactic body radiotherapy (SBRT)
    • +4 more
    • New York, New York
      Columbia University Irving Medical Center
    Sep 15, 2023

    Cell-Free DNA CHIP for Diagnosing Cancer

    Recruiting
    • Cancer of Pancreas
    • Non-Human Subject Research study.
    • Orlando, Florida
      University of Central Florida
    Nov 20, 2023

    3D Bioprinting for Personalized Treatment in Pancreatic Ductal

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
      • Beijing, Beijing, China
      • +1 more
      Jul 12, 2023

      Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Refractory Non-Small Cell Lung Cancer
      • Washington, District of Columbia
        Georgetown Lombardi Comprehensive Cancer Center
      Sep 1, 2023

      Pancreatic Ductal Adenocarcinoma

      Recruiting
      • PDAC - Pancreatic Ductal Adenocarcinoma
      • Pancreatic Cancer
      • Breath test
      • Collection of matched samples of breath, biofluids and pancreatic tissue
      • London, United Kingdom
        Imperial College Healthcare NHS Trust
      Feb 3, 2023

      Carcinoma, Pancreatic Ductal Trial in Trondheim (SonoVue, Chemotherapy)

      Completed
      • Carcinoma, Pancreatic Ductal
      • Trondheim, Norway
        Department of Radiology, St Olavs Hospital
      Jan 17, 2023

      Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

      Not yet recruiting
      • Metastatic Pancreatic Cancer
      • Durvalumab
      • Rintatolimod
      • Rotterdam, Zuid-Holland, Netherlands
        Erasmus MC
      Jun 23, 2023

      Pancreatic Ductal Adenocarcinoma

      Completed
      • Neoplasms Pancreatic
      • pancreatic cancer surgery
      • Hangzhou, Zhejiang, China
        First Affiliated Hospital, Medical College of Zhejiang Universit
      Sep 20, 2022

      PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

      Not yet recruiting
      • PDAC - Pancreatic Ductal Adenocarcinoma
      • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
      • (no location specified)
      Jul 9, 2023

      Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +2 more
      • Enfortumab vedotin
      • Kansas City, Kansas
        University of Kansas Cancer Center
      Jun 23, 2023

      HER-2 Expression in Pancreatic Duct Adenocarcinoma

      Completed
      • Pancreatic Adenocarcinoma
      • immunohistochemical approach
      • (no location specified)
      Sep 20, 2023

      Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

      Not yet recruiting
      • Locally Advanced Unresectable Pancreatic Adenocarcinoma
      • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
      • (no location specified)
      Jun 25, 2023

      Pancreatic Cancer Trial in New York (Chemotherapy, Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA))

      Not yet recruiting
      • Pancreatic Cancer
      • Chemotherapy
      • Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA)
      • New York, New York
        Tisch Hospital
      Feb 9, 2023